Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

RSS icon

Balancing act: Do benefits of cancer screening outweigh risks?

One of the more complex decisions in the cancer screening decision-making algorithm centers on the risk-benefit ratio. For patients in the screening pools, CT-based screening for lung and colon cancer meets the mark.

Given Imaging's PillCam COLON Cleared in Japan, World's Second Largest Healthcare Market

Given Imaging Ltd, (Nasdaq:GIVN), a world leader in gastrointestinal medical devices and pioneer of capsule endoscopy, today announced that PillCam(R) COLON has been cleared by Japan's Pharmaceuticals & Medical Devices Agency (PMDA) for diagnosis of colonic disease when colonoscopy is required but difficult to conduct, including patients unwilling or unable to undergo colonoscopy.

Location of colon cancer can raise risk of subsequent cancer up to 3-fold

The risk of a second primary cancer following colorectal cancer (CRC) is significantly higher than expected cancer incidence rates for those without CRC, according to a study published online July 15 in CANCER.

Childhood cancer survivors face, often overcome, infertility

Women who survived childhood cancer face a 50 percent higher risk of infertility than their siblings. However, the ultimate rate of conception among cancer survivors who are unsuccessful in becoming pregnant after one year of trying is nearly two-thirds, on par with eventual pregnancy among all clinically infertile women.

Cancer care pathways cut costs by 15%

Oncology pathways programs, which provide guidelines to encourage cost-effective treatments and eliminate unnecessary interventions, can cut costs and reduce the rate of hospital admissions across a regional payer network, according to a study published online June 18 in the American Journal of Managed Care.

Advanced prostate cancer treatments often used on patients who won’t benefit

Advanced treatment technologies for prostate cancer are increasingly being used on the wrong patients, according to a study published June 26 in JAMA.

Watchful waiting strategy could save $1B in prostate cancer treatment costs

If the number of men with newly diagnosed prostate cancer who opted for watchful waiting increased from 10 percent to 50 percent, the resulting savings would surpass $1 billion, researchers estimated in a study published June 18 in Annals of Internal Medicine. The authors noted that new molecular imaging techniques could improve classification of low-risk candidates and set the stage for a more conservative approach than the active surveillance model.

Women may delay CT colonography screening

Patient age and sex are useful for predicting risk of advanced neoplasia at screening CT colonography (CTC), but body mass index (BMI) and positive family history seem to have little impact, according to a study published online June 10 in Cancer.

Displaying 689 - 696 of 2554

Around the web

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.